Transplant Immunology

Increased CD16 expression on NK cells is indicative of antibody-dependent cell-mediated cytotoxicity in chronic-active antibody-mediated rejection.

Pretransplant angiotensin II type 1-receptor antibodies point to an increase in renal graft sub-intimal fibrosis in living- donor kidney transplant recipients.

Prevalence of antibodies to lung self-antigens (Kα1 tubulin and collagen V) and donor specific antibodies to HLA in lung transplant recipients and implications for lung transplant outcomes: Single center experience.

VEGF-C attenuates ischemia reperfusion injury of liver graft in rats.

Protective effect of rosiglitazone on chronic renal allograft dysfunction in rats.

Detection of engraftment of donor-derived antibody producing cells in a lung transplant recipient by anti-cytomegalovirus IgG avidity test.

Kinetics of antibody response to influenza vaccination in renal transplant recipients.

Adipose tissue-derived mesenchymal stem cells ameliorate bone marrow aplasia related with graft-versus-host disease in experimental murine models.

Regulatory effects of dermal papillary pluripotent stem cells on polarization of macrophages from M1 to M2 phenotype in vitro.

Tacrolimus exposure after liver transplantation for alcohol-related liver disease: Impact on complications.

Switching renal transplant recipients to belatacept therapy: results of a real-life gradual conversion protocol.

TLR2 and NODs1 and 2 cooperate in inflammatory responses associated with renal ischemia reperfusion injury.

Mannose binding lectin 2 gene polymorphisms in patients after renal transplantation with acute graft rejection.

Salvianolic acid B ameliorates liver injury in a murine aGvHD model by decreasing inflammatory responses via upregulation of HO-1.

Recurrent acute cellular rejection graded ISHLT 1R early after heart transplantation negatively affects long-term outcomes: The prognostic significance of 1990 ISHLT grades 1B and 2.

Banff lesions and renal allograft survival in chronic-active antibody mediated rejection.

iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers in serum of acute cellular rejection after liver transplantation.

Strategies to achieve immune tolerance in allogeneic solid organ transplantation.

Changes in serum KL-6 levels are associated with the development of chronic lung allograft dysfunction in lung transplant recipients.

Preliminary assessment of the feasibility of autologous myeloid-derived suppressor cell infusion in non-human primate kidney transplantation.

Can the Toll-like receptors 4 expression in peripheral blood mononuclear cells help assess the effectiveness of immunosuppression and the chance of a future good renal transplant function?

Peripheral CD19+CD24highCD38high B-regulatory cells in lung transplant recipients.

Effects of recombinant thrombomodulin therapy and soluble human leukocyte antigen-G levels during hematopoietic stem cell transplantation.

Prospective validation of the L-index reflecting both the intensity and duration of lymphopenia and its detailed evaluation using a lymphocyte subset analysis after allogeneic hematopoietic stem cell transplantation.

Human CTLA4-Ig therapy can give false-positive anti-pig antibody results in primates after xenotransplantation.

Collagen type-V is a danger signal associated with primary graft dysfunction in lung transplantation.

Identification of the immunological profile in rejection-free heart transplantation.

The prevention of tracheal graft occlusion using pioglitazone: A mouse tracheal transplant model study.

Jon van Rood: The pioneer and his personal view on the early developments of HLA and immunogenetics.

Effects of recombinant thrombomodulin on long-term prognosis after allogeneic hematopoietic stem cell transplantation.

Clinical use of an immune monitoring panel in liver transplant recipients: A prospective, observational study.

Endowing human CD8 T cells with a veto-like recognition capacity via the electroporation of MHC-I/CD3ζ mRNA.

A novel MyD88 inhibitor attenuates allograft rejection after heterotopic tracheal transplantation in mice.

Accuracy of the median channel shift in the flow cytometry for predicting complement dependent cytotoxicity crossmatching in kidney transplant candidates.

Prognostic value of C3d-fixing, preformed donor-specific antibodies in crossmatch-positive living kidney transplantation.

Low dose valganciclovir as cytomegalovirus prophylaxis in post-renal transplant recipients induced with alemtuzumab: A single-center study.

Benefits of a loading dose of tacrolimus on graft survival of kidney transplants in nonhuman primates

Negative impact of recipient SPRED2 deficiency on transplanted lung in a mouse model.

Mfn2 inhibits chronic rejection of the rat abdominal aorta by regulating TGF-β1 levels.

Profiles of B-cell subsets in immunologically stable renal allograft recipients and end-stage renal disease patients.

Immunological profiles of HIV-positive recipients of liver transplant.

Analysis of genetic and clinical risk factors of post-transplant thrombocytopenia in kidney allograft recipients.

Impact of immunosuppressive therapy on brain derived cytokines after liver transplantation.

Immunoglobulin abnormalities in 1677 solid organ transplant recipients. Implications for posttransplantation follow-up.

An enigmatic case of undiagnosed severe diarrhoea post living donor liver transplant.

The effect of a novel immunosuppressive drug, a PAK-2 inhibitor, on macrophage differentiation/polarization in a rat small intestinal transplantation model.

Circulating microvesicle protein is associated with renal transplant outcome.